Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

367.50p
   
  • Change Today:
    -2.50p
  • 52 Week High: 500.00
  • 52 Week Low: 362.00
  • Currency: UK Pounds
  • Shares Issued: 47.65m
  • Volume: 48,149
  • Market Cap: £175.11m
  • RiskGrade: 180
  • Beta: 0.03

Tristel flags forecast-busting full-year results

By Josh White

Date: Monday 22 Jul 2024

LONDON (ShareCast) - (Sharecast News) - Infection prevention products manufacturer Tristel released a robust trading update for the year ended 30 June on Monday, with revenues and pre-tax profits surpassing market expectations.
The AIM-traded company recorded a 16.4% increase in full-year revenue, reaching £41.9m, compared to £36m in 2023.

That growth exceeded Tristel's performance target of an annual average revenue growth of 10% to 15% over three years.

The company's adjusted profit before tax was anticipated to be no less than £8.0 million, representing a 29% increase from the prior year's £6.2 million and also exceeding market expectations.

Tristel said it remained debt-free and continued to generate cash, with cash balances rising to £11.6m as of 30 June, up from £9.5m a year earlier.

The firm's strong financial performance was put down to robust demand for Tristel's infection prevention products across all its geographical markets, including the United States and Canada.

"This is my last trading update before I hand over the reins to our incoming CEO in early September and I am delighted to report to shareholders that the business has delivered another strong trading performance and growth ahead of both analyst expectations and our own growth targets," said chief executive officer Paul Swinney.

"This is an exciting transition point for our Company as I pass the CEO baton on to Matt Sassone.

"Tristel has become a leading global player in a specific niche of the global infection prevention industry: the decontamination of non-lumened heat sensitive medical devices."

Swinney said that niche "sweeps up" many of the diagnostic tools used in hospitals ranging from ultrasound probes to small endoscopes.

"Looking to the future, we are confident that we will also become a leading player in the hospital surface disinfection market with our unique chlorine dioxide chemistry.

"We are all very excited for the company's future prospects."

At 0912 BST, shares in Tristel were up 6% at 477p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 367.50p
Change Today -2.50p
% Change -0.68 %
52 Week High 500.00
52 Week Low 362.00
Volume 48,149
Shares Issued 47.65m
Market Cap £175.11m
Beta 0.03
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average95.52% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average
Price Trend
30.82% below the market average30.82% below the market average30.82% below the market average30.82% below the market average30.82% below the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average
Income
48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average48.23% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
32.07% above the market average32.07% above the market average32.07% above the market average32.07% above the market average32.07% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-24 23-Nov-23
Paid 12-Apr-24 22-Dec-23
Amount 5.24p 7.88p

Trades for 10-Oct-2024

Time Volume / Share Price
15:54 2,700 @ 367.50p
15:54 2,700 @ 366.50p
14:44 134 @ 365.70p
14:29 1,366 @ 365.85p
14:23 28 @ 370.00p

Tristel Key Personnel

Finance Director Elizabeth Dixon
CEO Matthew (Matt) Giovanni Sassone

Top of Page